Avestar Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Avestar Capital, LLC

$951 Million
Q3 2024

A detailed history of Avestar Capital, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Avestar Capital, LLC holds 723 shares of REGN stock, worth $533,574. This represents 0.08% of its overall portfolio holdings.

Number of Shares

723

Previous 671 7.75%

Holding current value

$533,574

Previous $705,000 7.8%

% of portfolio

0.08%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $53,252 - $62,491	52 Added 7.75%	723 $760,000
Q2 2024 Aug 08, 2024	SELL	$883.2 - $1071.19 $15,014 - $18,210	-17 Reduced 2.47%	671 $705,000
Q1 2024 May 10, 2024	BUY	$902.69 - $993.35 $291,568 - $320,852	323 Added 88.49%	688 $662,000
Q4 2023 Feb 12, 2024	BUY	$775.18 - $881.7 $282,940 - $321,820	365 New	365 $320,000
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $21,329 - $24,834	-78 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$299.6 - $414.82 $2,097 - $2,903	-7 Reduced 8.24%	78 $21,000
Q1 2019 May 09, 2019	SELL	$372.08 - $439.57 $77,764 - $91,870	-209 Reduced 71.09%	85 $33,000
Q4 2018 Jan 25, 2019	SELL	$335.82 - $403.04 $18,134 - $21,764	-54 Reduced 15.52%	294 $87,000
Q3 2018 Oct 23, 2018	BUY	$351.14 - $408.51 $20,014 - $23,285	57 Added 19.59%	348 $122,000
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $7,399 - $8,969	26 Added 9.81%	291 $85,000
Q1 2018 May 10, 2018	BUY	$315.82 - $393.78 $29,055 - $36,227	92 Added 53.18%	265 $77,000
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $62,042 - $81,301	173	173 $45,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Regeneron Pharmaceuticals, Inc. Transaction History